Madrigal Pharmaceuticals (MDGL) EBIT Margin Growth (1y) (2011 - 2026)
Madrigal Pharmaceuticals (MDGL) EBIT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Madrigal Pharmaceuticals | 15.77 Bn | 15.54 Bn | - | 2,800.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,800.00 |
| Dec 31, 2025 | 4,628.00 |
| Sep 30, 2025 | 14,738.00 |
| Jun 30, 2025 | 108,820.00 |
| Sep 30, 2012 | -2.87 Mn |
| Jun 30, 2012 | -1.38 Mn |
| Mar 31, 2012 | -894,876.00 |
| Dec 31, 2011 | -825,478.00 |
| Sep 30, 2011 | -43,183.00 |
| Jun 30, 2011 | -542,230.00 |